LONDON and NEW YORK - Corvil, innovator of electronic trading and market data latency management systems, today announced Thomson Reuters Markets division as a new client of CorvilNet, the company’s core software platform. CorvilNet monitors, analyzes and optimizes electronic trading and market data applications against ultra-low latency objectives. Corvil, with operations in New York, London and Dublin, serves a global client base spanning exchanges; alternative trading platforms; proprietary trading groups; investment banks; broker-dealers; high-frequency and automated market making trading firms; hedge funds; and market service providers.
“Thomson Reuters Markets is dedicated to ensuring its global client base experiences end-to-end latency that will not exceed specified levels and we are confident CorvilNet will perform a crucial role in managing this ongoing process,” said Corvil CEO, Donal Byrne.
Thomson Reuters will use CorvilNet to manage a range of services and applications carried across their next generation global backbone network. CorvilNet’s unique feature set will allow Thomson Reuters to identify and eliminate latency bottlenecks, in addition to reducing the time and money spent diagnosing and fixing latency problems. In particular, Corvil’s support of SLA compliance will enable Thomson Reuters to assure the speed and quality of their services proactively, in a complex and dynamic environment.
“Our business demands the lowest possible latency in an ever growing traffic environment,” said Thomson Reuters Markets Global Head of Wide Area Network Engineering, Ayman Soliman. “We have chosen CorvilNet to help us optimize the global infrastructure and provide real time analytics in order to meet the business demands.”
CorvilNet enables clients to specify and report against precise latency and loss SLAs (service level agreements) for intra- and inter-party application flows; deploy microsecond monitoring for applications and service channels across networks; troubleshoot violations through automated event capture and root-cause analysis; and leverage real time data of anomalies in applications, networks and resource requirements into a more efficient and competitive electronic trading value proposition.
About Thomson Reuters
Thomson Reuters is the world’s leading source of intelligent information for businesses and professionals. We combine industry expertise with innovative technology to deliver critical information to leading decision makers in the financial, legal, tax and accounting, scientific, healthcare and media markets, powered by the world’s most trusted news organization.
Thomson Reuters shares are listed on the New York Stock Exchange (NYSE: TRI); Toronto Stock Exchange (TSX: TRI); London Stock Exchange (LSE: TRIL); and Nasdaq (NASDAQ: TRIN). For more information on Thomson Reuters, please visit www.thomsonreuters.com/about/
About Corvil
Corvil, pioneer of electronic trading and market data latency management systems, was founded in 2000 and operates from New York, London and Dublin. The company’s global client base spans exchanges; alternative trading platforms; proprietary trading groups; investment banks; broker-dealers; high-frequency and automated market making trading firms; hedge funds; and market service providers. Recognized as a technology innovator in latency management, Corvil’s products offer a complete solution for enhancing electronic trading, execution and market data including SLA (service level agreement) compliance, performance monitoring, event troubleshooting and infrastructure optimization. For more information on Corvil, please visit www.corvil.com.
Source: Corvil
Contact: Corvil, Collette Bird, +353-1-859-1040, E-mail: collette.bird at corvil.com
Related Press Releases
Thomson Reuters Completes Acquisition of Abacus Software Business From Deloitte LLPSeptember 30th, 2009 NEW YORK -
Thomson Reuters, the world's leading source of intelligent information for businesses and professionals, today announced that its Tax & Accounting business has completed the acquisition of the Abacus Enterprise suite of products and related business operations from Deloitte LLP, a leading professional services firm. The Abacus suite of products helps corporations and their advisors plan, comply, and remit income taxes and value added taxes (VAT), and, in addition to Abacus products, includes Workflow, Identity and P11D products.
Accovion Selects Liquent Insight PublisherJune 16th, 2009 PHILADELPHIA and LONDON - Contract Research Organization Chooses Thomson Reuters Software Solution
The Healthcare & Science business of Thomson Reuters today announced Accovion has purchased Liquent InSight(R) Publisher - a software solution used to quickly and easily create, review, amend and submit regulatory dossiers. Accovion is a full-service contract research organization (CRO).
Thomson Reuters Delivers Liquent Insight Regulatory Software to Linde HealthcareJune 14th, 2009 PHILADELPHIA and LONDON - Global Gases and Engineering Company Turns to Thomson Reuters for Comprehensive Regulatory Solution
The Healthcare & Science business of Thomson Reuters today announced Linde Healthcare has purchased Liquent Regulatory Software -- a solution specifically designed to meet the regulatory needs of life sciences organizations. Linde Healthcare is a global business unit of The Linde Group, a world-leading gases and engineering company.
King Fahd University For Petroleum & Minerals is First in Gulf Region to Purchase Web of Science(R) BackfilesJune 14th, 2009 PHILADELPHIA and LONDON - The Healthcare & Science business of Thomson Reuters today announced that King Fahd University For Petroleum & Minerals (KFUPM), has purchased Web of Science data back to 1900. KFUPM is the first university in the Saudi Arabia Consortia, and in the Gulf region, to purchase more than a century of vital data.
Thomson Reuters Powers Multimedia Experience on SmartphonesMay 10th, 2009 NEW YORK and LONDON - Thomson Reuters launches new mobile applications for the iPhone and BlackBerry, to better serve its audience of global, on-the-go business professionals. Following are two news releases detailing each application separately.
Innovation Nations: Thomson Reuters Analysis of 2008 World Patent Activity Finds U.S. Market Infused with Asian InnovationsMarch 24th, 2009 PHILADELPHIA - Global Intellectual Property Analysis Finds Foreign Companies Dominate
List of Top Ten U.S. Innovators While Chinese, European, Japanese and Korean
Rankings Showcase Homegrown Technologies
The IP Solutions business of Thomson Reuters released the results of its
2008 Global Innovation Study today, analyzing the leading innovators by key
region over the last year.
Thomson Reuters Partners With Egyptian Universities Libraries to Provide Research SolutionsMarch 24th, 2009 PHILADELPHIA and LONDON - The Healthcare and Science business of Thomson Reuters today announced
that Egyptian Universities Libraries (EUL) has selected Thomson Reuters to
provide research solutions to their consortium of university libraries. EUL
signed a multi-year contract with Thomson Reuters to provide Egypt's
researcher's access to ISI Web of Knowledge(SM).
Thomson Reuters Launches IDRAC(R) NotesMarch 22nd, 2009 PHILADELPHIA and LONDON - New Commenting Feature Facilitates Increased Collaboration With
Colleagues
The Healthcare and Science business of Thomson Reuters has launched
IDRAC(R) Notes, an add-on commenting feature to IDRAC. This will allow
colleagues within the same organization to create, update and share comments
attached to IDRAC PDF documents.
Thomson Reuters Names 'Hottest' Researchers and Papers of 2007-2008March 16th, 2009 PHILADELPHIA and LONDON - The Healthcare and Science business of Thomson Reuters today announced
the results of its annual roundup of the "hottest" researchers and research
papers. In its March/April issue of Science Watch, Thomson Reuters identified
the top 13 authors who fielded the highest numbers of Hot Papers in 2007-2008
as well as the most-cited research papers of 2008.
Thomson Reuters Publishes Pharma Matters White Paper, 'The Five Myths of Generic Competition'March 10th, 2009 PHILADELPHIA and LONDON - Unique Survey Shows Much Room for Originator Pharmaceutical Companies
to Improve Their Understanding of Generic Competition
The Healthcare and Science business of Thomson Reuters today released the
white paper, "The Five Myths of Generic Competition," highlighting what
originator pharmaceutical and biotech companies can do to improve their
forecasting of the likely timing, source and intensity of competition from
generic drugs. The findings in this white paper are based on an independent survey of
commercial professionals in pharmaceutical and biotech companies.
Related News
Thomson Reuters gets UK court approval for shares removal from London Stock ExchangeAugust 25th, 2009 UK court approves Thomson Reuters London delistingNEW YORK — Thomson Reuters Corp. said Tuesday that a UK court removed the last hurdle to pulling its shares from the London Stock Exchange and the Nasdaq.
Thomson Reuters 2Q profit up 52 percent as Reuters acquisition boosts revenueAugust 6th, 2009 Thomson Reuters 2Q profit up 52 percentNEW YORK — Thomson Reuters Corp. says second-quarter profit more than doubled from a year ago, helped by its 2008 acquisition of the Reuters news service.
Thomson Reuters reports higher 1Q earnings and sales on Reuters acquisitionMay 8th, 2009 Thomson Reuters reports higher 1Q earningsNEW YORK — Thomson Reuters Corp. says its first-quarter profit climbed 18 percent on growing revenue, mainly from the company's acquisition of Reuters last year.
Thomson Reuters 2Q profit doubles as Reuters acquisition boosts revenueAugust 6th, 2009 Thomson Reuters 2Q profit upNEW YORK — Thomson Reuters Corp. said Thursday its second-quarter profit more than doubled from a year ago, helped by its 2008 acquisition of the Reuters news service.
Thomson Reuters reports higher 1Q earnings on Reuters acquisitionMay 9th, 2009 Thomson Reuters 1Q earns up on Reuters acquisitionNEW YORK — Thomson Reuters Corp. said Thursday its first-quarter profit climbed 18 percent, mainly from the company's acquisition of Reuters last year.
Thomson Reuters 2Q profit doubles on Reuters acquisition, customer stabilization seenAugust 6th, 2009 Thomson Reuters 2Q profit up, stabilization seenNEW YORK — Thomson Reuters Corp. said Thursday its second-quarter profit more than doubled from a year ago, helped by its 2008 acquisition of the Reuters news service.
Eight Indian scientists honoured for groundbreaking researchApril 24th, 2009 NEW DELHI - Eight of India's leading scientists were Friday honoured with Thomson Reuters Research Excellence - India Research Front Awards for their groundbreaking work and influential contribution to global research and development. The eight awardees were presented with the accolade after their research was analysed using Thomson Reuters Research Front Methodology to assess their level of influence on specific scientific fields, Thomson Reuters said in a release here.
New topical spray is 'safe, effective treatment for premature ejaculation'April 27th, 2009 WASHINGTON - Science is trying its level best to improve people's sex lives - and the latest offering from scientists is a new topical spray, which has turned out to be a safe and effective treatment for premature ejaculation. Current treatment for premature ejaculation consists of topical creams with desensitizing agents which dull the penile skin and delay ejaculation.
Mayawati keen to speed up development projectsJune 18th, 2009 LUCKNOW - After being shaken by the Lok Sabha election drubbing and with an eye to the 2012 assembly polls, Uttar Pradesh Chief Minister Mayawati has decided to speed up development projects in her state in order to win back the electorate, official sources said. To accelerate implementation of infrastructure projects and to keep track of their progress, the chief minister has set up an eight-member Infrastructure Monitoring Committee, headed by the chief secretary.
Exxon Mobil profit falls 58 percent as lower crude, gas prices cut into earningsApril 30th, 2009 Exxon Mobil profits fall 58 percent to $4.6BHOUSTON — Exxon Mobil says its first-quarter profit fell 58 percent as the world's biggest publicly traded oil company, like smaller rivals, encountered far lower year-over-year oil and gas prices. Exxon Mobil Corp., based in Irving, Texas, said Thursday that earnings for the first three months of the year came to $4.6 billion, or 92 cents a share, down from $10.9 billion, or $2.02 a share, a year ago.
